Literature DB >> 21986356

Opinion paper: Quo vadis - EFSA?

G Reid1.   

Abstract

In times when human life and quality of life remain threatened by infectious diseases, increasing microbial resistance and a diminished armamentarium of treatments, you might think that the European Commission would urgently seek and encourage alternative approaches. On the contrary, the European Food Safety Authority (EFSA) has created a panel that has ignored good science, over-ridden peer-reviewed medical studies, and seems intent on breaking the back of a validated approach to infectious disease management, namely probiotics. The recent rejection of a simple and quite bland claim related to vaginal health emphasises the travesty of this bureaucracy. Herein, the science fights back and counters the critique of EFSA.

Entities:  

Mesh:

Year:  2011        PMID: 21986356     DOI: 10.3920/BM2011.0026

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  5 in total

1.  The changing hypothesis of the gut. The intestinal microbiome is increasingly seen as vital to human health.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2012-06-01       Impact factor: 8.807

2.  A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union.

Authors:  Julie Glanville; Sarah King; Francisco Guarner; Colin Hill; Mary Ellen Sanders
Journal:  Nutr J       Date:  2015-02-08       Impact factor: 3.271

3.  The Need to Focus on Therapy Instead of Associations.

Authors:  Gregor Reid
Journal:  Front Cell Infect Microbiol       Date:  2019-09-12       Impact factor: 5.293

4.  Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice.

Authors:  Rostyslav V Bubnov; Lidiia P Babenko; Liudmyla M Lazarenko; Viktoria V Mokrozub; Oleksandr A Demchenko; Oleksiy V Nechypurenko; Mykola Ya Spivak
Journal:  EPMA J       Date:  2017-10-10       Impact factor: 6.543

Review 5.  Has knowledge of the vaginal microbiome altered approaches to health and disease?

Authors:  Gregor Reid
Journal:  F1000Res       Date:  2018-04-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.